Product Information
GLIPIZIDE 5 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.0351 per EA under NDC 00591046001. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
5 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591046001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GLIPIZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074223On Market Since
2/27/1995
Pharmacological Classes
Price Statistics
The NADAC for GLIPIZIDE 5 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 11.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0351 per EA |
|---|---|
| All-time high | $0.0369 (Feb 16, 2022) |
| All-time low | $0.0238 (Jan 17, 2018) |
| 52-week high | $0.0360 |
| 52-week low | $0.0342 |
| Median price | $0.0323 |
| Average price | $0.0316 |
| Largest weekly change | -26.1% (Nov 20, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GLIPIZIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE 5 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.0351 per EA (NDC 00591046001), effective Jun 24, 2026.
How has the price of GLIPIZIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIPIZIDE 5 MG TABLET has risen 11.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLIPIZIDE 5 MG TABLET?
Since Nov 28, 2013, the NADAC for GLIPIZIDE 5 MG TABLET has ranged from a low of $0.0238 (Jan 17, 2018) to a high of $0.0369 (Feb 16, 2022), with a median of $0.0323 per EA.
Are there cheaper alternatives to GLIPIZIDE 5 MG TABLET?
12 NADAC-published products share the same active ingredient, strength, and dosage form as GLIPIZIDE 5 MG TABLET, but none are currently priced below it.
Who manufactures GLIPIZIDE 5 MG TABLET?
GLIPIZIDE 5 MG TABLET (NDC 00591046001) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification